FindMyKOL
Clinical trialNCT01726283CompletedObservational

Combined CXL//UV and PRK or LASIK in Forme Fruste Keratoconus or Eyes With Potential Risk of Ectasia

SponsorCxlusaEnrollment22Fruste KeratoconusRisk of Ectasia
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This study is being performed to evaluate the efficacy of ultraviolet-A (UVA)-induced cross-linking of corneal collagen (CXL) in strengthening and optimizing the biomechanical and biochemical stability of the cornea in patients with fruste keratoconus (FFKC), corneas that are suspicious for FFKC and corneas thought to be at higher risk of developing ectasia that will be undergoing laser vision correction.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Schwartz Laser Eye Center

    Scottsdale, Arizona, United States

  • Clear View Eye & Laser Medical Center

    San Diego, California, United States

  • the Center for Excellence in Eye Care

    Miami, Florida, United States

  • Tlc Laser Eye Center

    Rockville, Maryland, United States

  • Talamo Laser Eye Center

    Waltham, Massachusetts, United States

  • Minnesota Eye Consultants

    Minneapolis, Minnesota, United States

  • Cleveland Eye Clinic

    Breckville, Ohio, United States

  • Tlc Laser Eye Center

    Fairfax, Virginia, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Riboflavin
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Oct 2011
Primary completion
31 Jul 2014
Completion
31 Jul 2014
Last update posted
24 Aug 2015
Registered enrollment
22
Registry id
NCT01726283
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.